Sfoglia per Titolo
Replicability and Generalizability of Posttraumatic Stress Disorder (PTSD) Networks: A Cross-Cultural Multisite Study of PTSD Symptoms in Four Trauma Patient Samples
2018 Fried, E; Eidhof, M; Palic, S; Costantini, G; Huisman-van Dijk, H; Bockting, C; Engelhard, I; Armour, C; Nielsen, A; Karstoft, K
Replication is More than Hitting the Lottery Twice
2013 Asendorpf, J; Conner, M; De Fruyt, F; De Houwer, J; Denissen, J; Fiedler, K; Fiedler, S; Funder, D; Kliegl, R; Nosek, B; Perugini, M; Roberts, B; Schmitt, M; Van Aken, M; Weber, H; Wicherts, J
Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases
2013 Schuemie, M; Gini, R; Coloma, P; Straatman, H; Herings, R; Pedersen, L; Innocenti, F; Mazzaglia, G; Picelli, G; van der Lei, J; Sturkenboom, M
Replies to Comments and Additional Insights [Risposte ai commenti e nuove riflessioni]
2023 Salardi, S; Saporiti, M
Reply
2010 Vergani, P; Ornaghi, S; Ghidini, A
Reply
2017 Messerli, F; Hofstetter, L; Agabiti Rosei, E; Burnier, M; Elliott, W; Franklin, S; Grodzicki, T; Kario, K; Kjeldsen, S; Kostis, J; Laurent, S; Leenen, F; de Leeuw, P; Lund Johansen, P; Mancia, G; Narkiewicz, K; Papademetriou, V; Parati, G; Poulter, N; Redon, J; Rimoldi, S; Ruilope, L; Schiffrin, E; Schmieder, R; Schwartz, A; Sever, P; Sowers, J; Staessen, J; Wang, J; Weber, M; Williams, B
The reply
2013 Spagnolo, P; Luppi, F; Richeldi, L
Reply
2020 Sharman, J; O'Brien, E; Alpert, B; Delles, C; Hecht Olsen, M; Mcmanus, R; Padwal, R; Parati, G; Stergiou, G
Reply
2021 Norsa, L; D'Antiga, L
Reply : Have we attained the right control of hypertension? Consequences of the 2013 European Society of Hypertension/European Society of Cardiology and Eighth Joint National Committee recommendations
2014 Mancia, G; Fagard, R
Reply : Hypertensive urgencies and emergencies: Reducing the gap between guidelines and clinical practice
2014 Mancia, G; Fagard, R
Reply [to: Use of FibroScan–AST Score to Stratify High-Risk Nonalcoholic Steatohepatitis in US...]
2020 Ciardullo, S; Perseghin, G
Reply Comment on‘Sodium-glucose cotransporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease’ Tomoyuki Kawada
2022 Sarafidis, P; Ortiz, A; Ferro, C; Halimi, J; Kreutz, R; Mallamaci, F; Mancia, G; Wanner, C
Reply letter to “RE: Renal dysfunctions and clinical correlates in adolescents with restrictive anorexia nervosa”
2021 Riva, A; Nacinovich, R
Reply to "debilitating fatigue as a treatment indication in chronic hepatitis C"
2015 Pawlotsky, J; Aghemo, A; Back, D; Dusheiko, G; Forns, X; Puoti, M; Sarrazin, C
Reply to "Liver fibrosis assessed by transient elastography and albuminuria"
2021 Ciardullo, S; Ballabeni, C; Trevisan, R; Perseghin, G
Reply to "liver in mythology: A different version of Tityos' myth"
2012 Riva, M
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594
2020 Canta, A; Chiorazzi, A; Pozzi, E; Fumagalli, G; Monza, L; Meregalli, C; Carozzi, V; Rodriguez-Menendez, V; Oggioni, N; Nasstrom, J; Marmiroli, P; Cavaletti, G
Reply to Blood pressure target in chronic kidney disease
2013 Mancia, G; Fagard, R; Zanchetti, A
Reply to Comment on Resentini et al., 2020: “Ongoing exhumation of the Taiwan orogenic wedge revealed by detrital apatite thermochronology: The impact of effective mineral fertility and zero-track grains”
2020 Resentini, A; Malusa, M; Garzanti, E
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile